Feedback (LSE:FDBK) Change In Receivables : £-0.49 Mil (TTM As of Nov. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Feedback Change In Receivables?

Feedback's change in receivables for the quarter that ended in Nov. 2023 was £-0.21 Mil. It means Feedback's Accounts Receivable increased by £0.21 Mil from May. 2023 to Nov. 2023 .

Feedback's change in receivables for the fiscal year that ended in May. 2023 was £-0.01 Mil. It means Feedback's Accounts Receivable increased by £0.01 Mil from May. 2022 to May. 2023 .

Feedback's Accounts Receivable for the quarter that ended in Nov. 2023 was £0.44 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Feedback's Days Sales Outstanding for the six months ended in Nov. 2023 was 181.66.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Feedback's liquidation value for the six months ended in Nov. 2023 was £4.78 Mil.

Feedback Change In Receivables Historical Data

The historical data trend for Feedback's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback Change In Receivables Chart

Feedback Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Change In Receivables

Get a 7-Day Free Trial

-0.11

0.12

-0.01

0.05

-0.01

Feedback Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Nov22	May23	Nov23
Change In Receivables	Get a 7-Day Free Trial															0.08	-0.03	0.27	-0.28	-0.21

Feedback Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Nov. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.49 Mil.

Feedback (LSE:FDBK) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Feedback's Days Sales Outstanding for the quarter that ended in Nov. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.435	/	0.437	*	91
=	181.66

2. In Ben Graham's calculation of liquidation value, Feedback's accounts receivable are only considered to be worth 75% of book value:

Feedback's liquidation value for the quarter that ended in Nov. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5.372	-	0.914	+	0.75 * 0.435	+	0.5 * 0
=	4.78

Feedback Change In Receivables Related Terms

Thank you for viewing the detailed overview of Feedback's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Feedback (LSE:FDBK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT

Website

https://www.fbkmed.com

Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines